A detailed history of Cardinal Capital Management transactions in Johnson & Johnson stock. As of the latest transaction made, Cardinal Capital Management holds 111,345 shares of JNJ stock, worth $16.1 Million. This represents 2.86% of its overall portfolio holdings.

Number of Shares
111,345
Previous 107,453 3.62%
Holding current value
$16.1 Million
Previous $15.7 Million 14.89%
% of portfolio
2.86%
Previous 2.7%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$145.48 - $167.38 $566,208 - $651,442
3,892 Added 3.62%
111,345 $18 Million
Q2 2024

Jul 12, 2024

BUY
$144.38 - $157.78 $175,277 - $191,544
1,214 Added 1.14%
107,453 $15.7 Million
Q1 2024

Jul 12, 2024

BUY
$155.22 - $162.74 $871,715 - $913,947
5,616 Added 5.58%
106,239 $16.8 Million
Q1 2024

Apr 15, 2024

BUY
$155.22 - $162.74 $871,715 - $913,947
5,616 Added 5.58%
106,239 $16.8 Million
Q4 2023

Jul 12, 2024

SELL
$145.6 - $158.88 $45,572 - $49,729
-313 Reduced 0.31%
100,623 $15.8 Million
Q4 2023

Jan 26, 2024

SELL
$145.6 - $158.88 $45,572 - $49,729
-313 Reduced 0.31%
100,623 $15.8 Million
Q3 2023

Jul 12, 2024

BUY
$155.75 - $174.48 $144,068 - $161,394
925 Added 0.92%
100,936 $15.7 Million
Q3 2023

Oct 16, 2023

BUY
$155.75 - $174.48 $144,068 - $161,394
925 Added 0.92%
100,936 $15.7 Million
Q2 2023

Jul 12, 2024

SELL
$154.35 - $166.11 $961,291 - $1.03 Million
-6,228 Reduced 5.86%
100,011 $16.6 Million
Q2 2023

Jul 12, 2023

BUY
$154.35 - $166.11 $121,782 - $131,060
789 Added 0.8%
100,011 $16.6 Million
Q1 2023

Apr 18, 2023

BUY
$151.05 - $180.26 $99,541 - $118,791
659 Added 0.67%
99,222 $15.4 Million
Q4 2022

Jan 20, 2023

SELL
$160.2 - $179.79 $146,422 - $164,328
-914 Reduced 0.92%
98,563 $0
Q3 2022

Oct 21, 2022

SELL
$161.33 - $179.52 $21,940 - $24,414
-136 Reduced 0.14%
99,477 $16.3 Million
Q2 2022

Aug 04, 2022

BUY
$168.19 - $186.01 $109,155 - $120,720
649 Added 0.66%
99,613 $17.7 Million
Q1 2022

Apr 21, 2022

BUY
$158.14 - $179.59 $196,409 - $223,050
1,242 Added 1.27%
98,964 $17.5 Million
Q4 2021

Jan 18, 2022

SELL
$155.93 - $173.01 $5,301 - $5,882
-34 Reduced 0.03%
97,722 $16.7 Million
Q3 2021

Oct 21, 2021

SELL
$161.5 - $179.47 $209,142 - $232,413
-1,295 Reduced 1.31%
97,756 $15.8 Million
Q2 2021

Jul 14, 2021

BUY
$159.48 - $171.07 $68,735 - $73,731
431 Added 0.44%
99,051 $16.3 Million
Q1 2021

Apr 19, 2021

BUY
$153.07 - $170.48 $17,909 - $19,946
117 Added 0.12%
98,620 $16.2 Million
Q4 2020

Feb 01, 2021

BUY
$137.11 - $157.38 $110,647 - $127,005
807 Added 0.83%
98,503 $15.5 Million
Q3 2020

Oct 16, 2020

BUY
$140.38 - $153.83 $16,985 - $18,613
121 Added 0.12%
97,696 $14.5 Million
Q2 2020

Jul 16, 2020

SELL
$128.81 - $155.51 $29,755 - $35,922
-231 Reduced 0.24%
97,575 $13.7 Million
Q1 2020

Apr 20, 2020

SELL
$111.14 - $153.99 $183,047 - $253,621
-1,647 Reduced 1.66%
97,806 $12.8 Million
Q4 2019

Jan 21, 2020

SELL
$127.5 - $146.44 $87,975 - $101,043
-690 Reduced 0.69%
99,453 $14.5 Million
Q3 2019

Oct 18, 2019

SELL
$126.95 - $142.14 $4,697 - $5,259
-37 Reduced 0.04%
100,143 $13 Million
Q2 2019

Jul 08, 2019

SELL
$131.15 - $144.24 $127,608 - $140,345
-973 Reduced 0.96%
100,180 $14 Million
Q1 2019

Apr 11, 2019

SELL
$125.72 - $139.79 $20,115 - $22,366
-160 Reduced 0.16%
101,153 $14.1 Million
Q4 2018

Jan 15, 2019

SELL
$122.84 - $147.84 $14,372 - $17,297
-117 Reduced 0.12%
101,313 $13.1 Million
Q3 2018

Oct 25, 2018

SELL
$121.58 - $142.88 $34,650 - $40,720
-285 Reduced 0.28%
101,430 $14 Million
Q2 2018

Jul 25, 2018

BUY
$119.4 - $131.76 $1.17 Million - $1.29 Million
9,767 Added 10.62%
101,715 $12.3 Million
Q1 2018

Apr 25, 2018

SELL
$125.1 - $148.14 $212,044 - $251,097
-1,695 Reduced 1.81%
91,948 $11.8 Million
Q4 2017

Feb 01, 2018

SELL
$131.22 - $143.62 $118,098 - $129,258
-900 Reduced 0.95%
93,643 $13.1 Million
Q3 2017

Oct 24, 2017

BUY
$129.47 - $135.38 $12.2 Million - $12.8 Million
94,543
94,543 $12.3 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $378B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Cardinal Capital Management Portfolio

Follow Cardinal Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cardinal Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Cardinal Capital Management with notifications on news.